menu
    • menu

    Company profile for NanoAlvand

    Nanoalvand-PSE
    News
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit

    09 Dec 2024

    // PRESS RELEASE

    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects

    30 Nov 2024

    // PRESS RELEASE

    Introducing Vicrista® – A New Era in Pediatric Oncology

    03 Nov 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    NanoAlvand VB RM

    Contact Supplier

    Website

    CPhI WW Frankfurt

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content

    radio-compass-blog/how-trump-s-tariffs-on-imported-drugs-can-hurt-supply-chains-consumers-and-industry

    EVENTS

    DIGITAL CONTENT

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    PharmaCompass

    NanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Related CompaniesRelated Companies

    About

    NanoAlvand, founded in 2011, is a knowledge-based company dedicated to the manufacturing of advanced, highly potent pharmaceutical products for both domestic & global markets. With a steadfast commitment to quality, we merge cutting-edge knowledge in pharmaceutics with innovative technologies to deliver superior products. By harnessing up-to-date expertise & state-of-the-art technology, we guarantee the highest standards of quality. NanoAlvand also seeks for global partnerships as joint venture programs & expertise exchange through technology transfer to deliver its advanced pharmaceuticals to a wider world.

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    NanoAlvandIran Flag
    Country
    Country
    Iran
    Address
    Address
    Unit 52, 5th floor, No. 485, Between 63 St. & 65 St.,Asad Abadi St., Yousef A...
    Telephone
    Telephone
    +98 2191077339
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nanoalvand.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/nano-alvand-pharmaceutical-co-/
    youtube
    YouTube
    Twitter
    Twitter
    Contact Info
    Others

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CPhI North America

    Not Confirmed

    envelop Contact Supplier

    CPhI North America

    Post an Enquiry

    Meeting

    Digital content read-more

    Explore the latest content creation from this company

    CORPORATE CONTENT #SupplierSpotlight

    Product List 2025

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-83967.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    Corporate Presentation

    read-more

      https://www.pharmacompass.com/pdf/party/content/nanoalvand-party-content-90057.pdf

      Open PDFOpen PDF
      UploadUpload
      Key ShareShare

    NEWS #PharmaBuzz

    read-more
    read-more
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit
    Dr. Haleh Hamedifar to Speak at Forbes ME 30 Under 30 Summit

    09 Dec 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/197-forbes

    PRESS RELEASE
    09 Dec 2024
    Share Share
    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects
    Ifoxa® NanoAlvand’s New Chemotherapy Drug with Fewer Side Effects

    30 Nov 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/191-ifoxa-release

    PRESS RELEASE
    30 Nov 2024
    Share Share
    Introducing Vicrista® – A New Era in Pediatric Oncology
    Introducing Vicrista® – A New Era in Pediatric Oncology

    03 Nov 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/192-vicrista-release

    PRESS RELEASE
    03 Nov 2024
    Share Share
    NanoAlvand Continues to Lead: Recognized Iran's Top Exporters
    NanoAlvand Continues to Lead: Recognized Iran's Top Exporters

    22 Oct 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/9-news/190-top-exporters

    PRESS RELEASE
    22 Oct 2024
    Share Share
    Endoxyna®; A crucial medication with a novel solution formulation
    Endoxyna®; A crucial medication with a novel solution formulation

    29 Jun 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/36-endoxyna-release

    PRESS RELEASE
    29 Jun 2024
    Share Share
    Nibulin®; From the coast of Japan sea to hands of clinicians
    Nibulin®; From the coast of Japan sea to hands of clinicians

    08 Jun 2024

    // PRESS RELEASE

    https://www.nanoalvand.com/index.php/en/blog-en/10-releases/36-endoxyna-release

    PRESS RELEASE
    08 Jun 2024
    Share Share

    Drugs in Development

    read-more
    read-more
    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Ifoxa® by NanoAlvand Enhances Chemotherapy with Improved Side Effect Profile

    Details:

    Ifoxa (ifosfamide) is a cytotoxic drug that binds to DNA and inhibit DNA synthesis. Ifoxa is indicated for the treatment of malignant diseases.


    Lead Product(s): Ifosfamide

    Therapeutic Area: Oncology Brand Name: Ifoxa

    Study Phase: Approved FDFProduct Type: Cytotoxic Drug

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 30, 2024

    NanoAlvand

    01

    NanoAlvand

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Lead Product(s) : Ifosfamide

    Therapeutic Area : Oncology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Ifoxa® by NanoAlvand Enhances Chemotherapy with Improved Side Effect Profile

    Details : Ifoxa (ifosfamide) is a cytotoxic drug that binds to DNA and inhibit DNA synthesis. Ifoxa is indicated for the treatment of malignant diseases.

    Product Name : Ifoxa

    Product Type : Cytotoxic Drug

    Upfront Cash : Inapplicable

    November 30, 2024

    NanoAlvand

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Introducing Vicrista® – A New Era in Pediatric Oncology

    Details:

    Vicrista (vincristine sulphate) is a type of chemotherapy called a vinca alkaloid which interfere with microtubules and blocks cell growth by stopping mitosis. It is indicated for pediatric cancers.


    Lead Product(s): Vincristine Sulfate

    Therapeutic Area: Oncology Brand Name: Vicrista

    Study Phase: Approved FDFProduct Type: Cytotoxic Drug

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable November 03, 2024

    NanoAlvand

    02

    NanoAlvand

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Lead Product(s) : Vincristine Sulfate

    Therapeutic Area : Oncology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Introducing Vicrista® – A New Era in Pediatric Oncology

    Details : Vicrista (vincristine sulphate) is a type of chemotherapy called a vinca alkaloid which interfere with microtubules and blocks cell growth by stopping mitosis. It is indicated for pediatric cancers.

    Product Name : Vicrista

    Product Type : Cytotoxic Drug

    Upfront Cash : Inapplicable

    November 03, 2024

    NanoAlvand

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Endoxyna®; A Crucial Medication with A Novel Solution Formulation

    Details:

    Endoxyna is a novel liquid formulation of cyclophosphamide, to replace the previous freeze-dried products. It is indicated for the treatment of cancer


    Lead Product(s): Cyclophosphamide

    Therapeutic Area: Oncology Brand Name: Endoxyna

    Study Phase: Approved FDFProduct Type: Cytotoxic Drug

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable June 29, 2024

    NanoAlvand

    03

    NanoAlvand

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Lead Product(s) : Cyclophosphamide

    Therapeutic Area : Oncology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Endoxyna®; A Crucial Medication with A Novel Solution Formulation

    Details : Endoxyna is a novel liquid formulation of cyclophosphamide, to replace the previous freeze-dried products. It is indicated for the treatment of cancer

    Product Name : Endoxyna

    Product Type : Cytotoxic Drug

    Upfront Cash : Inapplicable

    June 29, 2024

    NanoAlvand

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Pomavid®; Our Dedication to Shaping Hope

    Details:

    Pomavid, a high-quality version of pomalidomide. Pomavid® is a new generation medication for the treatment of multiple myeloma, a type of blood cancer.


    Lead Product(s): Pomalidomide

    Therapeutic Area: Oncology Brand Name: Pomavid

    Study Phase: Approved FDFProduct Type: Cytotoxic Drug

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable June 07, 2024

    NanoAlvand

    04

    NanoAlvand

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Lead Product(s) : Pomalidomide

    Therapeutic Area : Oncology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Pomavid®; Our Dedication to Shaping Hope

    Details : Pomavid, a high-quality version of pomalidomide. Pomavid® is a new generation medication for the treatment of multiple myeloma, a type of blood cancer.

    Product Name : Pomavid

    Product Type : Cytotoxic Drug

    Upfront Cash : Inapplicable

    June 07, 2024

    NanoAlvand

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    • Development Update
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Wellosia®; Prioritizing our Patients' Well-Being

    Details:

    Wellosia (ozanimod) is a S1P modulator, small molecule drug candidate, which is indicated for the treatment of relapsing forms of multiple sclerosis & moderately to severely active ulcerative colitis.


    Lead Product(s): Ozanimod

    Therapeutic Area: Neurology Brand Name: Wellosia

    Study Phase: Approved FDFProduct Type: Other Small Molecule

    Sponsor: Inapplicable

    Deal Size: Inapplicable Upfront Cash: Inapplicable

    Deal Type: Inapplicable February 02, 2021

    NanoAlvand

    05

    NanoAlvand

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Lead Product(s) : Ozanimod

    Therapeutic Area : Neurology

    Highest Development Status : Approved FDF

    Partner/Sponsor/Collaborator : Inapplicable

    Deal Size : Inapplicable

    Deal Type : Inapplicable

    DEALS_DEV arrow-down

    Wellosia®; Prioritizing our Patients' Well-Being

    Details : Wellosia (ozanimod) is a S1P modulator, small molecule drug candidate, which is indicated for the treatment of relapsing forms of multiple sclerosis & moderately to severely active ulcerative colitis.

    Product Name : Wellosia

    Product Type : Other Small Molecule

    Upfront Cash : Inapplicable

    February 02, 2021

    NanoAlvand

    Stock Recap
    #PipelineProspector

    Data Compilation
    #PharmaFlow

    Virtual Booth

    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    Listed Dossiers

    read-more
    read-more

    01

    Brand Name : Xybrone

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Abiraterone Acetate

    NanoAlvand

    Dosage Form : Film Coated Tablet

    Brand Name : Xybrone

    Dosage Strength : 250MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    02

    Brand Name : Xybrone

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Abiraterone Acetate

    NanoAlvand

    Dosage Form : Film Coated Tablet

    Brand Name : Xybrone

    Dosage Strength : 500MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    03

    Brand Name : Trisenal

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Arsenic Trioxide

    NanoAlvand

    Dosage Form : Vial

    Brand Name : Trisenal

    Dosage Strength : 10MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    04

    Brand Name : Leukaza

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Azacitidine

    NanoAlvand

    Dosage Form : Vial

    Brand Name : Leukaza

    Dosage Strength : 100MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    05

    Brand Name : Intyma

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Baricitinib

    NanoAlvand

    Dosage Form : Film Coated Tablet

    Brand Name : Intyma

    Dosage Strength : 2MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    06

    Brand Name : Intyma

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Baricitinib

    NanoAlvand

    Dosage Form : Film Coated Tablet

    Brand Name : Intyma

    Dosage Strength : 4MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    07

    Brand Name : Bendanit

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Bendamustine Hydrochloride

    NanoAlvand

    Dosage Form : Vial

    Brand Name : Bendanit

    Dosage Strength : 25MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    08

    Brand Name : Bendanit

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Bendamustine Hydrochloride

    NanoAlvand

    Dosage Form : Vial

    Brand Name : Bendanit

    Dosage Strength : 100MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    09

    Brand Name : Alvocade

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Bortezomib

    NanoAlvand

    Dosage Form : Vial

    Brand Name : Alvocade

    Dosage Strength : 1MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    10

    Brand Name : Alvocade

    Iran
    arrow
    CPhI WW Frankfurt
    Attending
    • fda
    • EDQM
    • WHO-GMP
    Virtual BoothNanoAlvand is the entrance to Global Markets as a trusted Highly Potent Products manufacturer.

    Regulatory Info :

    Registration Country : Iran

    Bortezomib

    NanoAlvand

    Dosage Form : Vial

    Brand Name : Alvocade

    Dosage Strength : 3.5MG

    Packaging :

    Approval Date :

    Application Number :

    Regulatory Info :

    Registration Country : Iran

    NanoAlvand

    Product
    Web Link

    Stock Recap
    #PipelineProspector

    Market
    Place

    Only 10 entries up to this point, click to access all click full view read-more
    click full view
    Full Screen ViewFULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

    ABOUT THIS PAGE

    Contact NanoAlvand and get a quotation

    NanoAlvand is a supplier offers 28 products (APIs, Excipients or Intermediates).

    Find a price of Abiraterone Acetate bulk offered by NanoAlvand

    Find a price of Azacitidine bulk offered by NanoAlvand

    Find a price of Bortezomib bulk offered by NanoAlvand

    Find a price of Busulfan bulk offered by NanoAlvand

    Find a price of Cabazitaxel bulk offered by NanoAlvand

    Find a price of Carfilzomib bulk offered by NanoAlvand

    Find a price of Caspofungin bulk offered by NanoAlvand

    Find a price of Cladribine bulk offered by NanoAlvand

    Find a price of Dactinomycin bulk offered by NanoAlvand

    Find a price of Enzalutamide bulk offered by NanoAlvand

    Find a price of Epoprostenol Sodium bulk offered by NanoAlvand

    Find a price of Eribulin bulk offered by NanoAlvand

    Find a price of Everolimus bulk offered by NanoAlvand

    Find a price of Fludarabine Phosphate bulk offered by NanoAlvand

    Find a price of Fluorouracil bulk offered by NanoAlvand

    Find a price of Ibrutinib bulk offered by NanoAlvand

    Find a price of Idarubicin Hydrochloride bulk offered by NanoAlvand

    Find a price of Lenalidomide bulk offered by NanoAlvand

    Find a price of Methotrexate bulk offered by NanoAlvand

    Find a price of Mitoxantrone bulk offered by NanoAlvand

    Find a price of Mycophenolic Acid bulk offered by NanoAlvand

    Find a price of Ozanimod bulk offered by NanoAlvand

    Find a price of Palbociclib bulk offered by NanoAlvand

    Find a price of Plerixafor bulk offered by NanoAlvand

    Find a price of Ruxolitinib Phosphate bulk offered by NanoAlvand

    Find a price of Thiotepa bulk offered by NanoAlvand

    Find a price of Tofacitinib Citrate bulk offered by NanoAlvand

    Find a price of Vincristine Sulfate bulk offered by NanoAlvand

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search